Laboratory diagnosis of antiphospholipid syndrome

1. <div><p>Roubey R.A.S. Immunology of the antiphospholipid antibody syndrome. Arthr. Rheum., 1996, 39, 1444-1454</p><p>Hughes G.R.V. The antiphospholipid syndrome: ten years on. Lancet, 1993. 342. 341-344 V Насонов Е.Л. Антмфосфолмпидный синдром. М., Лит- re pa, 2004</p><p>Калашникова Л.А. Неврология антифоефолипидного синдрома. М., Медицина, 2003</p><p>Harris E.N. The Second International Anticardiolipin Standartization Workshop/The Kingston Antiphospholipid Study (KAPS) GroupAm.J.Clin. Pathol., 1990. 94. 476-484</p><p>Galli М., Comfurius P., Maassen C. el al. Anticardiolipin antibodies (АСА) directed not to cardiolipin but to a plasma protein cofactor. Lancet, 1990, 335, 1544-1547</p><p>Matsuura E,, lgarashi Y., Fugimoto М., et al. Anticardiolipin cofactor(s) and different diagnosis of autoimmune disease. Lancet, 1990, 336, 177-178</p><p>McNeil H.P., Simpson R.J. Chesterman C.N., Krilis S.A. Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: B2-glycoprotein I (apoliprotein H). Proc.Natl.Acad.Sci.USA, 1990, 87. 4120-4124</p><p>Brandt J.T. Triplett D.A., Alving B., Scharrer t. Criteria for the diagnosis of lupus anticoagulants: an update. Thromb.Haemost., 1995, 74, 1185-1190.</p><p>Pierangeli S.S. Stewart М., Silva L.K., Harris E.N. An antiphospholipid wet workshop: 7th International Svmposium on Antiphospholipid Antibodies. J.Rheumathol., 1998, 25, 156-160</p><p>Wilson W.A., Gharavi A.E. Koike T. et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthr. Rheum., 1999. 42, 1309-1311</p><p>Reddel S.W., Krilis S.A. Testing for and clinical significance of anticardiolipin antibodies. Clin.Diagn.Lab.ltnmunol., 1999, 6, 775-782</p><p>Harris E.N., Pierangeli S.S. "Equivocal" antiphospholipid syndrome. J.Autoimmunity, 2000, 15, 81-85</p><p>Баркаган З.Г., МомотА.П., Цывкииа Л.П., и др. Принципы лабораторной диагностики антифоефолипидного синдрома. Клинлаблиагностика, 2000, 3, 47-51</p><p>Александрова Е.Н., Насонов Е.Л., Ковалев В.Ю. Количественный нммуноферментный метод определения антител к кардиолипину в сыворотке крови. Кпин.рев- матол., 1995, 4, 35-39</p><p>Tincani A., Balestrieri G., Allegri F. et al. Overview on anticardiolipin ELISA standartization. J.Autoimmunity, 2000, 15, 195-197</p><p>Escalante A. Brey R.L., Mitchell B.D. et al. Accuracy of anticardiolipin antibodies in identifying a history of thrombosis among patients with systemic lupus erythematosus. Am.I.Med., 1995,98, 559-565</p><p>Wasmuth J.C., Minarro D.O., Homrighausen A. et al. Phoshpholipid autoantibodies and the antiphospholipid antibody syndrome: diagnostic accuracy of 23 methods studied by variation in ROC curves with number of clinical manifestations. Clin.Chem. 2002.48.1004-1010</p><p>Musial J., Swadzba J., Motyl A. et al. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis. J.Rheumatol., 2003,30,723-730</p><p>Александрова E.H., Новиков A.A., Решетняк Т.М. и соавт. Антитела к Ь2-гликопротенну-1 и антитела к кар диолипину при антифосфолипидном синдроме: анализ чувствительности и специфичности. Клин.мед. 2003,9,25-31</p><p>Guerin J., Feighery С., Sim R.B. et al. Antibodies to B2- glycoprotein-l A specific marker for the antiphospholipid syndrome. Clin.Exp.Immunol., 1997,109.304-309</p><p>Delkova D., Gil-Aquado A., Lavilla P. et al. Do antibodies to ?2-glycoprotein I contribute to the better characteriza lion of the antiphospholipid syndrome ? Lupus, 1999,8.430438</p><p>Amengual O., Atsumi Т., Khamashta M.A. et al. Specificity of ELISA for antibody to B2-glycoprotein 1 in patients wilh antiphospholipid syndrome. Br.J.Rheumatol., 1996,35.1239-1243</p><p>Horbach D.A., Oort E.V., Donders R.C.J.M. Lupus anticoagulant is the strongest risk factor for both venous and artherial thrombosisi in patients wich systemic lupus erythematosus. Tromb.Haemost., 1996,76.916-924</p><p>Roubey R. A. S., Maldonado M.A., Byrd S.N. Comparison of an enzimelinked immunosorbent assay for antibodies to ?2-glycoprotein I and a conventional anticardiolipin immunoassay. Arthr. Rheum.,1996,39.1606-16072</p><p>Day H.M., Thiagarajan P., Ahn.C. et al. Antibodies to B2- glycoprotein I in systemic lupus erylhehematosus and primary antiphospholipid syndrome: clinical correlations in comparison with other antiphospholipid antibody tests. J. Rheumatol. 1998,25,667-674</p><p>Reber G. Arvieux J., Comby E. et al. Multicenter evaluation of nine commercial kits for the quantitation of anticardiolipin antibodies. The working group on methodologies in haemostasis from the GEHT (groupe d'Etudes sur le hemostasis et la thrombose). Thromb.Haemost., 1995,73,444-452</p><p>Andrian M.A., Colonna F., Morio F. et al. Comparison of different kits in the detection of auloantibodies to cardiolipin and beta2 glycoprotein I. Rheumatol. (Oxford), 2004,43,181-185</p><p>McNeil H.P., Chesterman C.N., Krilis S.A. el al. Immunology and clinical importance of antiphospholipid antibodies. Adv.lmmunol., 1991,49,193-280</p><p>Boffa M.C., Berard М., Sugi T. et al. Antiphosphatidulethanolamine antibodies as the only antiphospholipid antibodies detected by ELISA II Kininigen reactivity. J.Rheumatol.,1996,23,1375-1379</p><p>Matsuura E., lgarashi Y. Fujimoto M. et al. Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor. J.Immunol., 1992,148,3885-3891</p><p>Oosting J.D., Derkscn R.H.W.M.,Bobbin K.I.W. et al. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein С or protein S: an explanation for their pathogenic mechanism? Blood, 1993. 81. 2618-2625</p><p>Sugi Т., McIntyre J.A. Autoantibodies to phos- phaiidylethanolamine (PE) recognize a kininogen-PE complex. Blood, 1995, 86. 3083-3089</p><p>Alarcon-Segovia D., Deleze М., Oria C.V. et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicinc, 1989, 68, 353-365</p><p>Couchock S., Fort J., Munoz S. et al. False positive ELISA tests for anticardiolipin antibodies in sera from patients with repited abortious, rheumatologic disorders and primary biliary cirrosis: correlation with elevated polyclonal IgM and implications for patients witch repeated abortion. Clin. Exp. Immunol., 1998,73,289-294</p><p>Adopian M.S. Boctor F.N., Peter J.B. el al. False-positive test result for IgM anticardiolipin antibody due to IgM rheumatoid factor. Arthr.Rheum., 1988,31,1212-1213</p><p>Hasselaar P., Triplett D.A., La Rue A. et al. Heat treatment of serum and plasma induces false positive results in the antiphospholipid antibody ELISA. J.Rheumatol., 1990,17,186-191</p><p>Cabiedes J., Cabral A.R., Alarcon-Segovia D. Hidden antiphospholipid antibodies in normal human sera circulate as immune complexes whose antigen can be removed by heat. acid, hipermolar buffers or phospholipasc treatment. EurJ.Rheumatol., 1998,28,2108-2114</p><p>Malsuda J., Sailon N. Gohchi К. et al. Distinguising B2- glycoprotein I dependent (systemic lupus erithematosus type) and independent (syphilis type) anticardiolipin antibody witch tween 20. Br.J.Haematol., 1993,85,799-802</p><p>Arvieux J., Roussel B. Influence of Tween 20 on rhe detection of B2-glycoprotein 1 - dependent anticardiolipin antibodies. Br.J.Haematol., 1994,87,443-444</p><p>Cabral A.R., Cabiedes J., Alarcon-Segovia D. Tween-20 detaches cardiolipin from ELISA plates and maker ^nticar- diolipin antibodies undetectable regardless of the presence of B2-glycoprotein I. J.Immunol.Methods.,1994,175,107- 114</p><p>Hunt J.E., McNeil H.B., Morgan G.J. et al. A phospholipid-B2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection. Lupus, 1992, 1, 75-81</p><p>Roubey R.A. Antigenic specifities of antiphospholipid antibodies implications for clinical laboratory testing and diagnosis of the antiphospholipid syndrome. Lupus, 1996,5,425430</p><p>McCarthy J.M., wagenknecht D.R., McIntyre J.A. Activity of antiphospholipid antibody ELISA cofactor in different animal sera. J.Clin.Lab.Anal., 1994,8,167-171</p><p>Arvieux J., Darnige L., Hachulla E.et al. Species specificity of anti-B2 glycoprotein I autoantibodies and its relevance to anticardiolipin antibody quantitation. Thromb.Haemost., 1996,75,725-730</p><p>Matsuura E., Igarashi Y., Yasuda Т., Triplett D., Koike T. Anticardiolipin antibodies recognize beta 2-glycoprotein 1 structure altered by interacting with an oxygen modified solid phase surface. J.Exp.Med.,1994,179,457-462</p><p>Hunt J., Krilis S. The fifth domain of beta2-glycoprotein I containes a phosphilipid binding site (cys281 -cys288), and region recognised by anticardiolipin antibodies. J.Immunol., 1994,152, 653-659</p><p>OhKura N., Magihara Y., Yoshimura T. et al. Plasmin can reduse the function of human B2 glycoprotein I by clearity domain V into a nicked form. Blood,1998.91,4173-4179</p><p>Roubey R.A.S., Eisenberg R.A., Harper M.F. et al. "Anticardiolipin" autoantibodies recognize B2-glycoprolein I in the absence of phospholipid. Importance of antigen density and bivalent binding. J.Immunol., 1995,154,954960</p><p>Arvieux J., Regnault V., Hachulla E. et al. Heterogeneity and immunochemical properties of anti-beta 2 -glycoprotein I autoantibodies. Tromb.Haemost., 1998,80,393-398</p><p>Koike Т., Matsuura E. Anti-B2 -glycoprotein I antibodie: specificity and clinical significance. Lupus, 1996,5,378-380</p><p>Sheng Y„ Kandiah D.A., Krilis S.A. et al. Anli-B2 -glycoprotein I antibodies from patients with the "antiphospholipid" syndrome bind to B2-giycoprotein I witch low affinity dimerization of B2-glycoprotein I induces a significant increase in anti- B2-glycoprotein I antibody affinity. J.Immunol., 1998,161,2038-2043</p></div><br />